The earliest clues often look like a cranky stomach or a bladder having a bad week, which is exactly how they slip past women ...
Ovarian cancer can be a difficult-to-detect disease early on because its symptoms often are vague and easily mistaken. Here ...
The disease is diagnosed approximately 22,000 times every year in the U.S. with more than 12,000 deaths expected in 2026.
Median overall survival of 15.9 months in Cyclin E1-positive PROC, with 1–5 prior lines of therapy; safety profile in DENALI ...
A review in the Journal of Ovarian Research surveys clinical trial evidence on CAR-T, TCR-T, TIL and NK cell therapies, ...
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% ...
Current screening methods often can’t detect ovarian cancer until later stages. To improve survival rates, researchers are ...
PregaTips on MSN
Does having children affect your risk of ovarian cancer?
Having children may affect your risk of ovarian cancer. Pregnancy and breastfeeding can reduce the number of times you ...
The Phase 1 study by Lilly assessed Sofe-M plus bevacizumab in 33 women with platinum-sensitive ovarian cancer (PSOC).
In a phase 1 trial of patients with platinum-sensitive high-grade ovarian cancer, a personalized neoantigen vaccine plus ...
Sofe-m was acquired by Lilly as part of its 2023 takeover of French biotech Mablink Bioscience and its PSARLink ADC ...
Before they could legally drive a car, vote or take their first sip of alcohol, ovarian cancer left these Australian girls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results